BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 147 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $124,000 | -75.1% | 40,050 | -70.9% | 0.00% | -100.0% |
| Q3 2021 | $497,000 | +227.0% | 137,595 | +223.8% | 0.00% | +100.0% |
| Q2 2021 | $152,000 | -8.4% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $166,000 | -6.7% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $178,000 | +10.6% | 42,500 | -1.6% | 0.00% | 0.0% |
| Q3 2020 | $161,000 | -21.1% | 43,200 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $204,000 | +31.6% | 46,800 | +14.7% | 0.00% | 0.0% |
| Q1 2020 | $155,000 | -45.2% | 40,800 | -8.9% | 0.00% | -50.0% |
| Q4 2019 | $283,000 | +71.5% | 44,800 | +14.0% | 0.00% | +100.0% |
| Q3 2019 | $165,000 | -11.8% | 39,300 | -2.5% | 0.00% | 0.0% |
| Q2 2019 | $187,000 | -23.0% | 40,300 | -12.0% | 0.00% | -50.0% |
| Q1 2019 | $243,000 | +77.4% | 45,800 | +23.3% | 0.00% | +100.0% |
| Q4 2018 | $137,000 | +34.3% | 37,158 | +1.6% | 0.00% | 0.0% |
| Q3 2018 | $102,000 | -12.1% | 36,582 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $116,000 | +24.7% | 39,294 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $93,000 | -35.0% | 41,384 | -14.6% | 0.00% | 0.0% |
| Q4 2017 | $143,000 | -10.6% | 48,466 | -10.4% | 0.00% | -50.0% |
| Q3 2017 | $160,000 | -20.4% | 54,098 | -24.7% | 0.00% | -33.3% |
| Q2 2017 | $201,000 | +76.3% | 71,800 | +19.9% | 0.00% | +50.0% |
| Q1 2017 | $114,000 | +0.9% | 59,900 | -7.3% | 0.00% | 0.0% |
| Q4 2016 | $113,000 | -9.6% | 64,650 | +39.3% | 0.00% | 0.0% |
| Q3 2016 | $125,000 | -29.4% | 46,400 | -15.3% | 0.00% | -60.0% |
| Q1 2016 | $177,000 | -39.8% | 54,750 | -10.7% | 0.01% | -37.5% |
| Q4 2015 | $294,000 | -19.9% | 61,300 | -7.1% | 0.01% | -20.0% |
| Q3 2015 | $367,000 | -99.9% | 65,950 | +8.1% | 0.01% | 0.0% |
| Q2 2015 | $485,560,000 | +88505.8% | 61,000 | +16.9% | 0.01% | 0.0% |
| Q1 2015 | $548,000 | -99.9% | 52,200 | +26.2% | 0.01% | 0.0% |
| Q4 2014 | $497,027,000 | -29.4% | 41,350 | +0.4% | 0.01% | -33.3% |
| Q3 2014 | $704,108,000 | +57.7% | 41,200 | +11.4% | 0.02% | +50.0% |
| Q2 2014 | $446,590,000 | +75.2% | 37,000 | +22.5% | 0.01% | +66.7% |
| Q1 2014 | $254,888,000 | +94.9% | 30,200 | +36.0% | 0.01% | +100.0% |
| Q4 2013 | $130,758,000 | – | 22,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|